A manufacturer of anti-inflammatory medicine for infants

A manufacturer of anti-inflammatory medicine for infants recently discovered that a batch of its medicine still in production contained improper and potentially harmful quantities of certain compounds. The manufacturer immediately issued a recall of all recently shipped batches, but some executives went on to propose that all remaining batches be destroyed as well, even though it would cost the company millions of dollars in lost revenue.

The proposal to destroy the remaining batches of medicine depends on which of the following assumptions?


A. The company will be able to recoup any lost revenue through sales of other medicines.
B. It cannot feasibly be determined whether the remaining batches of medicine are salable.
C. The public will not be aware of the destruction of the remaining medicine.
D. Destruction of the remaining batches would ensure that improper quantities of the compound are not present in any of the company's products.
E. Some of the remaining batches of medicine do not contain harmful quantities of the compound in question.